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INTRODUCTION
Development of cytotoxic test in vitro has considerably contributed to the progress of
immunology against tumor cells from experimental animal and from several types of human
neoplasia. Tumor specific transplantation antigen has been found in all experimental
tumors. Chemical carcinogen induced and viral induced tumors have been mostly used
as models of autochthonous tumors.
Spontaneous mammary tumor (SMT) may provide a model useful in such investigations
since they have been a convenient model for the investigations between tumor and host
defenses. Both in vivo (Morton,!) Vaage,2) Irie3» and in vitro (Hellstrom,4) Heppner,5)
Le Francois6» studies have shown the specific nature of the immunological response to such
tumors. In most of these investigations SMT from different lines of C3H mice have been
employed. In the present study, SMT from DBA/2Ha-DD mice have been used. A
quantitative in vitro cytotoxicity test which based on colony inhibition (7) by immune lympho-
cytes have been used to study the host response against primary spontaneous mammary
tumors (4, 5). The use of an in vitro test for the direct measurement of cytotoxicity on
cultured SMT cells is the subject of the present report. In this assay, the cytotoxic activity
of syngeneic and allogeneic lymphocytes has been tested against tumor cells in confluent
and complete monolayer.
MATERIALS AND METHODS
Tumors and Mice: 2-3 month old mice of following strains have been used; DBAI
2Ha-DD, DBA/2J and C57BI/6Ja. The incidence of SMT in DBA/2Ha-DD mouse is about
70%' Most tumors appear at the age of 7-12 months. SMT can be transplanted from the
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primary host to syngeneic DBA/2Ha-DD mice. In this study, both immunizing and target
cells were from either SMT or first transplant generations of SMT in DBA/2Ha-DD mice.
Preparation of Tumor and Kindney Cell Suspensions: Tumors were excised aseptically,
and freed of obviously necrotic portions. Small tumor pieces (2-3 mm3) were placed in
a 1 : 1 mixture of 0.20/0 trypsin solution and Eagle's minimum essential medium with Eagle's
balanced salt solution which was enriched 3 times in its content of amino acids and vitamins
(3 X E medium). Trypsinization was then carried out at 37° with gentle stirring for 60
minutes. If a lot of tumor cells would be needed, this trypsinization was repeated 2 times
at 60 minutes intervals. The suspension was centrifuged and the cells were washed twice
m 3 X E medium. Cell viability in the final suspension was determined by the trypan blue
exclusion method and was found to be 50-700~. All calculations were in each case based
upon viable cells only. Kidneys from 10-20 day old mice were treated in the same way to
obtain suspensions of normal cells. In some comparative experiments tumor cell suspensions
were obtained by shaking and mechanical teasing without trypsinization, and no differences
m experimental patterns could be discerned with respect to trypsinized cells.
Immunization and Preparation of Effector Cells: For immunization tumor cells
suspensions were injected intraperitoneally (i.p.) into mice of each of the three lines used,
taking advantage of the fact that SMT cells do not grow rapidly in the peritoneal cavity of
syngeneic DBA/2Ha-DD mice. Otherwise specified immunizing cells were injected 3
times at 7 day intervals. Spleen cells were obtained 7 to 14 days after last immunization.
Spleen cell suspensions were prepared as follows. The spleen capsule was cut with fine
scissors and the cells teased gently into cold 3 X E medium with blunt forceps. After one
washing, the red blood cells were removed by hypotonick shock; 2 volumes of distilled water
were added to 1 volume of cell suspension in medium for 20 seconds and isoosmolarity was
then restored by adding medium 10 times in excess. After washing, the cells were centri-
fuged for 5 minutes at 1500 rpm and resuspended at the desired concentration.
Tissue Culture: Primary cultures were prepared for each experiment. 3 X 107 viable
tumor cells or kidney cells were added to 30 ml of 3 X E medium supplemented with 100/0
heat inactivated fetal calf serum and incubated at 37°C. The medium was usually changed
on the second day to discard dead cells and cell debris. When the growth of the cells reached
the stage of confluent monolayer (5th or 6th day of culture), the primary culture was used as
a source of cells for secondary cultures on which performed the cytotoxicity tests. The
secondary culture of tumor cells thus prepared was found to be homogeneous and suitable
for the test.
Cytotoxicity Test: Cell from primary cultures were collected after trypsinization (0.2%
trypsin). After two washings in 3 X E medium, 2 X 104 viable cells in 0.2 ml 3 X E medium
were plated on each well of a Micro Test II Plate (Falcon Plastics No. 3040) as shown in
Fig. 1. Only roughly half of these cells could attach on the well surface and divide. After
24-48 hours incubation at 37°C in 50/0 CO2 in air, the cells formed a confluent monolayer on
the whole surface of the well bottom. The medium was removed and these monolayer were
washed once with fresh medium. Spleen lymphocyte to target cell ratio of either 400 : 1
or 200 : 1, or 100 : 1. This ratio was established based on the observation that the number
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Fig. 1. Micro-plates for cytotoxic test.
A (left side) Terasaki Plate. B (right side) Micro Test II Plate (Falcon Plastics No. 3040).
of SMT cells at the time of lymphocytes addition, as found in control wells, was approximately
2 to 3 X 104 cells/well. After 48 hours of further incubation under the same conditions,
lymphocytes were removed and the attached target cells were fixed in absolute methanol and
stained by Giemsa. A semi-quantitative method was used for the evaluation of monolayer
damage. In double-blind checks by two investigators, the monolayer was evaluated ac-
cording to five categories as follows;
(---) .. .intact monolayer in the well.
(+) scattered defects (holes) in the monolayer.
(+t) confluent destructed areas.
(+tt) extensive damage, with islands of intact monolayers.
(tHt) completely destructed monolayer.
RESULTS
1. Development of the Cytotoxicity Test.
The optimal conditions for culturing SMT cells were established with reference to the
medium used. Comparing the results obtained with the media tested, namely RPMI1640,
Eagle's minimum essential and 3 X E, it became apparent that the best growth rate was
achieved in 3 X E medium. The neoplastic nature of the cultured cells was repeatedly demon-
strated by injecting these cells back into syngeneic, irradiated (250 R) or non-irradiated,
DBA/2Ha-DD mice; tumor growth was achieved in 100% of the animals after the sub-
cutaneous injection of 105 cultured cells.
The survival of the DBA/2Ha-DD spleen lymphocytes in culture was studied as a
function of the type and amount of serum supplement in the medium (Fig. 2). Similar
results were obtained regardless of whether fetal calf serum or syngeneic mouse serum was
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Fig. 2. Viability of D BA/2Ha-DD spleen cells (4 X107/ml) in 3 X Eagle's
medium containing serum at different concentrations.
X- --X 10% DBA/2Ha-DD serum, 0---0 10% fetal calf
serum, 6. 6. 1% DBA/2Ha-DD serum, 0- -0 1% fetal
calf serum, .---. no serum.
used as a serum supplement. With 10% serum supplement, more than 60% of the lympho-
cytes were viable, according to the trypan blue exclusion test, 48 hours after plating, which
corresponds to the time required for completion of the cytotoxicit y test.
It is known that lymphocytes in vitro occur the blastic transformation spontaneously.
The effect of fetal calf serum content in the culture medium on the rate of blasti c trans-
formation was, therefore, studied in this experiment. N umber of large transformed lympho-
cytes was increasing with the percentage of the fetal calf serum in medium (Fig. 3). As
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Fig. 3. The effect of fetal calf serum content in medium on the lymphocyte
transformation.
















































Fig. 4. The effects of numbers of immunizing cells on monolayer damage.
~ immune lymphocytes from mice which were repeated 3 times
injection of 5 X 107 SMT cells intraperitoneally. l'Z22l immune lym-
phocytes from mice which were repeated 3 times injections of 107
SMT cells intraperitoneally. 0 lymphocytes from mice which were
non·injected.
transformation is rather the expression of nutritional requirement of metabolically active
lymphocytes during the process of transformation. Though 3 X E medium supplemented
with 100/0 fetal calf serum has been used in all these cytotoxicity experiments, it must be
taken into consideration in this point if the blastic transformation of lymphocytes willl be
measured.
The effects of numbers of immunizing cells on monolayer damage have studied. Intra-
peritoneal injection of SMT cells can be used for immunization of syngeneic hosts, because
in this system it does not grow when SMT cells are transplanted intraperitoneally. After
repeating 3 times injections of 107 or 5 X 107 SMT cells into DBAj2Ha-DD mice, the activity
of spleen lymphocytes against SMT monolayer was cell number dependant as shown in
Fig. 4.
II. Study of Cell-Mediated Responses to SMT.
The cytotoxic effects of spleen lymphocytes on SMT cells in confluent monolayer were
studied with effector cells obtained under conditions where the immunization was by SMT
inoculation into allogeneic mice across H2 (C57Blj6Ja), into allogeneic mice with H2 (DBA,!
2]) or into syngeneic mice (DBAj2Ha-DD).
The cytotoxic activity of sensitized lymphocytes from each of the three mouse strains
used was found to be considerably higher against SMT cells in monolayer than against mouse
kidney cells. In the experiment summarized in Fig. 5, 107 SMT cells were inoculated
intraperitoneally 3 times at 7 day intervals, and effector spleen cells were obtained 7 day
after the last immunization. In each case 2 sets of differences were compared, namely a)
the difference between the cytotoxicity of immunized and non-immunized spleen lymphocytes
against SMT cells in monolayer, and b) the difference between responses to SMT and kidney
cells in monolayer. The best results in terms of specificity of antitumor cytotoxicity were

























Fig. 5. Cytotoxic effect of spleen cells from C57Bl/6Ja (upper set), DBAJ2J
(middle set) or DBA/2Ha-DD (lower set) mice on either SMT (left
side) or DBA/2Ha·DD mouse kidney cell monolayers (MKC). The
donors of sensitized cells were immunized with 10 7 SMT cells 3 times
at weekly intervals. Effector cells were harvested 1 week after the last
immunization (solid bars). Open bars represent cells from non-immunized
donors. The effector/target cell ratios were as indicated on the abscissa.
obtai.ned at an effector to target cell ratio of 200 to 1 or 100 to 1. At these ratios, the cyto-
toxicity of effector cells from non-immunized mice was similar on both tumor and kidney
cell. .In contrast, the cytotoxicity of effector cells from immunized mice on tumor target
cells was significantly higher, indicating specificity of response. Reratively minor differens
in cytotoxicity were seen among cells from the three mouse lines used, and were evident es-
sentially only at an effector to target cell ratio of 100 to 1. The decreasing order of cytotoxicity
with cells from C57Bl/6]a, DBA/2] and DBA(2Ha-DD mice is consistent with expectations,
based on the histocompatibility differences involved.
DISCUSSION
There are good reasons to believe that the resistance of properly immunized mice against
syngeneic tumor transplants has an immunological explantation (8, 9, 10, 11, 12, 13, 14, 15).
These studies carried out in inbred animals. Since transplantation techniques can not be
satisfactorily employed in such work, in vitro tests are necessary. Several systems, namely
neutralization test and tissue culture, have been developed by which cellular immune reactions
against tumor antigens can be detected and quantitated;
A). Neutralization Test: so-called neutralization test were introduced by Winn (16) and
used by him (17), Klein & Sjogren (10), Old et al (18), and Kitano (19) to demonstrate cell
-mediated immune reaction. They are based on the finding that small lymphocytes (from
lymph node or spleen) from mice which have been immunized against the H-2 antigens of
another mouse strain can inhibit the growth in vivo of tumor carrying the respective H-2
antigens, if tumor cells and samll lymphocytes are mixed in vitro and inoculated into
Vol. 6 No. 2 March, 1973
- 99-
syngeneic recipients. The recipients are usually X-irradiated with a sublethal dose (250-400
R) in order to decrease their immunological reactivity against the transplanted cells.
B). Tissue Culture: tissue culture assays were introduced as a more sensitive tool than
the neutralization test for studies on lymphocyte-mediated reactions to target tumor cells.
Rosenau and Moon (20) published a study of target cell destruction by immune allogeneic
lymphoid cells. Mouse L cells (of C3H origin) were seeded into culture tubes. 24 hours
after the tubes had been seeded, the medium was removed and each tube received spleen cells
from BALBjc mice which had been repeatedly immunized against C3H. Immune spleen
cells were found to aggregate around the target cells within approximately 18 hours after they
were added to the cultures, whereas no aggregation was observed in the control.
The colony inhibition (Cn technique has been used to investigate the cellular immunity
to a variety of tumors in mouse and in human. It was introduced by Hellstrom (7) who
studied polyoma tumors, against which a cellular immunity had already been demonstrated
with neutralization test. She found that lymph node cells from polyoma-immune mice
reduced target cell colony formation.
Valuable information on such responses has been obtained by the application of in
vitro colony inhibition procedures (4, 5, 7, 21, 22, 23). These methods, although very useful
in studies of cellular responses and of phenomena related to humoral blocking factors, provide
only an indirect measure of cytotoxicity since they are based on the prevention of colony
formation. After due consideration of these points, a new method in this paper which was
modified from original CI Test (7) and from MCI (23) make it a rule to measure a direct
damage of target cells in a cell-mediated cytotoxicity. In therapeutically oriented studies
it seems, also, important to evaluate the interactions between immune host responces and
drugs based on a direct evaluation of cytotoxic effects on target tumor cells.
Cell-mediated cytotoxicity has been studied using as a target monolayers of established
tumor cell lines in culture (23) as well as primary cultures of human origin (4). The procedure
of a new method was implemented using primary cultures from primary or first transplant
generation mouse mammary tumors as a source of target cells. Cytotoxicity was evaluated
based on effects on confluent monolayers. Effector cells were obtained from normal mice
or from mice immunized with cells obtained from primary tumors. Because at the time
that mammary tumor cells monolayers are confluent a reasonably constant number of cells
are present in each well, defined ratios of effector to target cells could be established. More-
over, a direct semi-quantitative comparison was made between cytotoxicity on tumor and
normal cells, and between effects of sensitized and non-sensitized lymphocytes.
Spontaneous mammary tumors were long considered nonantigenic since the trans-
plantation methods used to detect antigens in experimentally induced neoplasms failed to
reveal any immunity to spontaneous mouse mammary tumors (8, 11), until it was shown
by Weiss et al (24) that such tumors have a common antigen against which transplantation
immunity can be built up in mice which are mammary tumor virus-free. The fact that
mammary tumors are "spontaneous" make them particularly relevant models for human
neoplasms. Heppner and Pierce (5), therefore, applied the CI assay to mammary carcinomas
which had appeared in BALBjefC3H mice which contained MTV by foster nursing on C3H.
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His conclusion was that cellular immunity can, indeed, be demonstrated against tumor
specific transplantation antigen (TSTA) of spontaneous tumors and that spontaneous
mammary carcinomas appear to have individually distinct TSTA in addition to the common
antigens previously detected by transplantation test.
On the other hand, author applied this new method, which confluent target monolayer
was usually used, to spontaneous mammary carcinomas which had appeared in DBA/2Ha-
DD mice. Cultured SMT cells by bottle cl;llture were plated into wells of Falcon Plate.
24-48 hours after plating, the medium and floating SMT cells were removed, then each
wells in Falcon Plate received spleen cells from DBA/2Ha-DD, DBA/2J, and C57Bl/6Ja
which had been immunized with SMT cells (107) 3 times. The controls received non-immune
spleen cells from those 3 strains. Another controls for target cells were, also, used kidney
cells from them. 48 hours after lymphocytes were added, they were washed out and the
damages of monolayer were evaluated by five categories as described in method. In this
study, cellular immuni ty against TSTA of spontaneous mammary tumors as same as Heppner
had been demonstrated as shown Fig. 5. But the presence of typical mammary tumor virus
particles was noted by electron microscopy. Thus, it is likely that virus-related antigens
are present on these cells and may be recongnized particularly in DBA/2J and C57Bl/6Ja
mice, both of which have a low incidence of SMT. My attempt in future will be made to
discriminate between different types of antigenic specificities presumably expressed on SMT
cells.
The low susceptibility to chemotherapy makes it difficult to study the interrelationships
between drug treatments and immune responses in vivo. Since in syngeneic systems based
on established transplantable tumors the participation of immunity to the curative effects
of chemotherapy is in many cases essential (25, 26, 27, 28), it seems important to study these
interrelationships also in autochthonous tumor systems. The initial studies described herein
led to the establishment of in vitro procedures which may be usefully employed to monitor
the effects of drugs on both SMT cells and effector cells, when drugs are given either to cell
donors or are added to the test culture. These applications, and the study of drug effects on
possible blocking phenomena, are the subject of current investigations.
SUMMARY
A new quantitative in vitro test for the direct measurement of cytotoxicity on confluent
and complete monolayer of SMT cells was designed with Micro Test Plate. The tumor
used develops with high frequency in the DBA/2Ha-DD mouse, and is specific for this
mouse since it grows in syngeneic host but not in DBA/2J or C57Bl/6Ja mice.
1) With 10~1o serum supplement regardless of whether fetal calf serum or syngeneic
mouse serum, more than 600/0 of the lymphocytes were viable at 48 hours culture after plating.
2) N umber of blastic transformation of lymphocytes was increasing with the percentage
of the fetal calf serum in 3 X E medium.
3) The activity of immune lymphocytes against SMT monolayer was cell number-
dependant which was intraperitoneally immunized.
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4) The cytotoxicity of immune lymphocytes was greatest with cells from C57B1/6Ja
mIce, less marked with cells from DBA/2J mice and least with cells from DBA/2Ha-DD
mIce. Moreover, its cytotoxicity was greater against SMT monolayer than against MKC
monolayer.
5) Therefore, it can be concluded that cellular immunity can be demonstrated between
against aHo-antigen and against tumor specific transplantation antigen of SMT. This
method can, also, be consider to be a good one for cytotoxicity in vitro test of cellular im-
munity.
ACKNOWLEDGEMENT
The authores are very grateful to Dr. Enrico Mihich, who is a director of Cancer Drug
Center at Roswell Park Memorial Institute, for furnishing them with an opportunity to
carry out this study in his laboratories in 1969-1972.
REFERENCES
Demonstration of Tumor-Specific Immunity Against Antigens Unrelated to
Virus in Spontaneous Mammary Adenocarcinomas. J. Nat. Cancer Inst.
Nat!. Cancer Inst. MonographThe Immune Response and the Homograft Reaction.
1) Morton, D. L., et a!.:
the Mammary Tumor
42: 289-301, 1969.
2) Vaage, ]. and Weiss, W.: Immunization Against Spontaneous and Autografted Mouse Mammary
Carcinomas in the Autochthonous C3HjC rgl Mouse. Cancer Res. 29: 1920-1926, 1969.
3) Irie, R. F.: Antigenic Cross-reactivity between Primary Spontaneous Mouse Mammary Tumors and
Their Transplantable Ascites Tumors. Cancer Res. 31: 1682-1689, 1971.
4) Hellstrom, I. et al.: Demonstration of Cell-mediated Immunity to Human Neoplasms of Various
Histological Types. Int.]. Cancer 7: 1-16, 1971.
5) Heppner, G. H. and Pierce, G.: In Vz"tro Demonstration of Tumor-Specific Antigen in Spontaneous
Mammary Tumors of Mice. Int.]. Cancer 4: 212-218, 1969.
6) LeFrancois, D. et a!.: Evalution of Cell-mediated Immunity in Mice Bearing Tumors Produced by
a Mammary Carcinoma Cell Line. Influence of Tumor Growth, Surgical Removal, and Treatment
with Irradiated Tumor Cells. J. Nat. Cancer Inst. 46: 981-987, 1971.
7) Hellstrom, I.: A Colony Inhibition (CI) Technique for Demonstration of Tumor Cell Destruction
by Lymphoid Cells In Vz"tro. Int. J. Cancer 2: 65-68, 1967.
8) Foley, E. J.: Antigenic Properties of Methylcholanthrene-induced Tumors in Mice of the Strain
of Origin. Cancer Res. 13: 835-837, 1953.
9) Prehn, R. T. and Main, J. M.: Immunity to Methylcholanthrene-induced Sarcomas. ]. Nat. Cancer
Inst. 18: 769-778, 1957.
10) Klein, E. and Sjogren, H. 0.: Humoral and Cellular Factors in Homograft and Isograft Immunity
against Sarcoma Cells. Cancer Res. 20, 452-461: 1960.
11) Revesz, L.: Detection of Antigenic Differences in Isologous Host-tumor Systems by Pretreatment
with Heavily Irradiated Tumor Cells. Cancer Res. 20, 443-451: 1960.
12) Weiss, D. E. et a1.: Immunology of Spontaneous Mammary Carcinomas in Mice. II. Resistance
to a Rapidly and a slowly developing Tumor. Cancer Res. 25: 451-457, 1965.
13) Takeda, K. and Aizawa, M.: Saishin-igaku (Japan), 19: 474-478, 1964.
14) Kitano, M. and Okada, Y.: A Study on Transplantation Immunity of Ehrlich Ascites Tumor and
Methylcholanthrene-induced Tumor in Mice with Special Reference to Local Immunity of Lymph
N odes draining the Site of Sensitization. Bul. Chest Dis. Res. lnst. Kyoto U niv. 1: 1-17, 1968.
15) Kitano, M. et a1.: Studies on Transplantation Immunity of Methykholanthrene-induced Tumor by
Use of Transplantation in Lymph Nodes and of Diffusion Chamber. Exp. Med. Surg. 27: 357-383,
1969.
16) Winn, H. J.:
-102- M. KITANO and V. UJHAZY Bull. Chest Dis. Res. Inst. Kyoto Univ.
2: 113-138, 1959.
17) Winn, H. J.: The Participation of Complement in Isoimmune Reactions. Ann. N. Y. Acad. Sci.
101: 23-45, 1962.
18) Old, L. J. et al.: In "Cell-bound Antibodies" (B. Amos & H. Koprowski, eds.), 89-99, Wistar Inst.
Press, Philadelphia, Pennsylvania, 1963.
19) Kitano, M.: An Experimental Study on Transplantation Immunity of Tumors. Bul. Chest Dis.
Res. Inst. Kyoto Univ. 1: 91-137, 1968.
20) Rosenau, W. and Moon, H. D.: Lysis of Homologous Cells by Sensitized Lymphocytes in Tissue
Culture. J. Nat. Cancer Inst. 27: 471-478, 1961.
21) Heppner, G. H. and Kopp, J. S.: A Dilute Agar Colony Inhibition (CI) Test for Studying Cell-
mediated Immune Responses Against Tumor Cells. Int. J. Cancer, 7: 26~33, 1971.
22) Heppner, G. H.: In Vitro Studies on Cell-mediated Immunity Following Surgery in Mice Sensitized
to Syngeneic Mammary Tumors. Int. J. Cancer, 9: 119-125, 1972.
23) Takasugi, M. and Klein, E.: The Methology of Microassay for Cell-mediated Immunity (MCI).
In "In Vitro Methods in Cell-mediated Immunity", 415-421, B. R. Bloom, & P. R. Glade, Academic
Press, 1971.
24) Weiss, D. W. et al.: Acquisition of Heightened Resistance and Susceptibility to Spontaneous Mouse
Mammary Carcinomas in the Original Host. Cancer Res. 24: 732-741, 1964.
25) Mikulska, Z. B. et al.: Evidence for an Immunological Reaction of the Host Directed Against Its
Own Actively Growing Primary Tumor. J. Nat. Cancer Inst. 36: 29-35, 1966.
26) Mihich, E.: Combined Effects of Chemotherapy and Immunity against Leukemia L1210 in DBA/2
Mice. Cancer Res. 29: 848-954, 1969.
27) Mihich, E.: Modification of Tumor Regressions by Immunologic Means. Cancer Res. 29: 2345-
2350, 1969.
28) Mihich, E.: Preclinical Evaluation of the Interrelationships between Cancer Chemotherapy and
Immunity. Prediction of Response in Cancer Therapy, Nat. Cancer Institute Monograph, 34: 90-
102, 1971.
